Fundraising FoxTrialjectory
6 known investors
Find your way into Trialjectory
Sign up to see every warm intro you have to Trialjectory
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Trialjectory team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Leal Health (formerly TrialJectory) operates an AI-powered decision support platform that matches cancer patients to personalized treatment and clinical trial options based on their specific diagnosis. It serves cancer patients directly, offering a free service supported by a team of PhDs, MDs, nurses, and social workers, and also provides trial-matching tools for oncologists.
Investors · 6
How we know: ICONYC labs's portfolio page · Not right? Tell us
How we know: Insight Partners's portfolio page · funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Funding
SEC filings, press & company announcements$20M disclosed across 1 round · 2022
- $20MSeries AFeb 2022 · 2 sources
Insight Partners (lead), Contour Venture Partners, JAL Ventures, Rho Capital, TIA Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Trialjectory do?
- Leal Health (formerly TrialJectory) operates an AI-powered decision support platform that matches cancer patients to personalized treatment and clinical trial options based on their specific diagnosis. It serves cancer patients directly, offering a free service supported by a team of PhDs, MDs, nurses, and social workers, and also provides trial-matching tools for oncologists.
- Who are Trialjectory's investors?
- Trialjectory's investors include ICONYC labs, Insight Partners, TIA Ventures, Contour Venture Partners, JAL Ventures Ltd., Rho Capital Partners.
- How much funding has Trialjectory raised?
- Trialjectory has disclosed $20M raised across 1 round.